Skip to Content

SUNDAY, 21 APRIL 2019, 14:20

Business

Ford Announces Cost Efficiencies, Plans To Invest in Driverless Technology Wisely

14 September 2016 at 21:05 PM, via Bidness Etc

Ford Motor Company (NYSE:F) announced to keep things steady with its future investments in the driverless car technology. Last month, the company announced to launch fully autonomous car for ride-hailing companies as early as 2021. However, the car maker will not be matching up the heavy investments spent by its rivals, such as General Motors or Toyota.

Here’s How Apple New iPhones Have Proven to be a Success

14 September 2016 at 19:59 PM, via Bidness Etc

Apple Inc's (NASDAQ:AAPL) latest iPhones might not have impressed many, but they have secured record-breaking pre-orders, according to news shared by T-Mobile and Sprint. This news about preordered devices certainly comes as a tailwind, as the stock is reported to be up more than 3% in today’s trading session, and is expected to surge further.

Freeport-McMoRan Deal Addresses Anadarko Major Criticisms: Here’s How

14 September 2016 at 19:21 PM, via Bidness Etc

Anadarko Petroleum agreed to acquire the Gulf of Mexico (GoM) assets from Freeport-McMoRan Inc. (NYSE:FCX) for $2 billion on September 13. Even though in a low oil environment, the multi-billion dollar deal might seem expensive, the acquisition agreement seems to be accretive to the company’s future production, earnings, and free cash flow (FCF). Analysts at several research firms have also...

Hereand#039;s Why Aerie Pharmaceuticals Stock Is on the Rise Today

14 September 2016 at 18:12 PM, via Bidness Etc

Aerie Pharmaceuticals Inc. (NASDAQ:AERI) stock has been on an upward momentum since the early hours today – up almost 7% – and soared to fresh 6-month highs. Trading activity has also been quite robust so far, as it has already exchanged hands 0.87 million times, which reflects approximately 2x the average daily trading volume of 0.43 million shares.

Celgene: Do Top Line Results of GED-0301 Present an Upside?

14 September 2016 at 17:56 PM, via Bidness Etc

Celgene Corporation (NASDAQ:CELG), the biotech giant, is finally reaping the results of its enhanced efforts to beef up research and development via licensing medicines from other companies. Its new treatment aimed at Crohn’s disease has yielded top line preliminary results from a Phase 1 study meant to analyze the efficacy of oral GED-0301 in endoscopic as well as clinical outcomes.

Are Times Tough for Wells Fargo ?

14 September 2016 at 17:05 PM, via Bidness Etc

Wells Fargo & Co. (NYSE: WFC) is in hot water these days as its stock has gone down nearly 6% over the past one week, reflecting serious dent in investor confidence. The bank also lost its most valuable bank title to JPMorgan Chase & Co. yesterday.

  1. Pages:
  2. 1
  3. ...
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15